Upgrade to SI Premium - Free Trial

JPMorgan Starts Telix Pharmaceuticals Ltd (TLX:AU) (TLX) at Overweight

June 1, 2026 12:55 AM
JPMorgan analyst Chris Cooper initiates coverage on Telix Pharmaceuticals Ltd (TLX:AU) (NASDAQ: TLX) with a Overweight rating and a price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Intl Ratings New Coverage